Project Grant 2035857
Award Date
3/1/21
Completion Date
8/31/21
Dollars Obligated
$256K
Funding Federal Agency
National Science Foundation
Awarding Federal Agency
Division of Industrial Innovation
Awardee
Fibrosix Inc. (HLLEW3GUYDM5)
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48823, USA
Similar Awards
The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...
The National Science Foundation awarded a $255,981 Small Business Innovation Research Phase I Project Grant to Frezent Biological Solutions Inc. of Valhalla, NY under the Engineering (CFDA 47.041) federal grant program. The grant funds the development of a novel peptide inhibitor of the coronavirus papain-like protease as a prophylactic and antiviral therapeutic for COVID-19, to be administered via inhalation. The Engineering program seeks to improve quality of life and economic strength...
The National Science Foundation Division of Industrial Innovation awarded MBF Therapeutics Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) from January 1, 2022 to December 31, 2022. The grant funds the development of a protective T cell vaccine for SARS CoV-2 (COVID-19). The Engineering program supports innovation, creativity and excellence in engineering research and education to improve quality of life and economic strength. This award furthers those...
This Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provided $255,943 to Athem LLC from February 15, 2021 through March 31, 2022. The grant funded the development of a medical device to isolate and purify therapeutic antibodies from recovered COVID-19 donors. The NSF Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award aimed to advance those goals by...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to White Rock Therapeutics under the Engineering federal grant program (CFDA 47.041). The grant will support development of an ACE2 decoy as a pan-coronavirus therapeutic from January 2022 to December 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award will fund initial research...
The National Science Foundation awarded a $220,000 Project Grant to the University of Connecticut under the Engineering (47.041) federal grant program. The award will fund development of a compact, field-portable biophotonics instrument for automated analysis and identification of blood cells impacted by COVID-19. The instrument aims to provide real-time sensing and diagnosis capabilities with high accuracy, specificity and sensitivity for potential early detection of COVID-19 infections. It...
Nellone Therapeutics Inc. received a $242k National Science Foundation SBIR Phase I Project Grant under the Engineering federal grant program to develop regulation of hyperinflammation and cell survival therapies for severe lung tissue damage from viral infections such as COVID-19. The award period is April 1, 2021 through March 31, 2022. As part of NSF's mission to promote innovation and U.S. competitiveness, this SBIR Phase I grant supports Nellone's proposed research to advance a NELL1/NV1...
This $247,457 National Science Foundation project grant funded research on coupling COVID-19 respiratory droplet adsorption and photocatalysis through metal organic frameworks. The grant was awarded to Framergy Inc. on June 15, 2021 under the Engineering (47.041) federal grant program. The objective was to develop materials and techniques to capture and deactivate SARS-CoV-2 virus particles through the end date of November 30, 2021. The Engineering program seeks to improve quality of life and...
The National Science Foundation awarded Medchem Partners LLC a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) for the period of August 1, 2021 through July 31, 2022. The grant funds the development of novel inhaled nitric oxide therapy for pulmonary treatments related to COVID-19. The Engineering program seeks to improve quality of life and economic strength through engineering research and innovation. This award supports Medchem Partners' work advancing new...
Florica Therapeutics, Inc. was awarded a $275,678 Project Grant from the National Science Foundation Division of Industrial Innovation under the Engineering (47.041) federal grant program. The grant will support research from January 15, 2021 through December 31, 2021 to develop hypothalamus stem cell exosomes for the treatment of COVID-19. As part of its mission to improve lives and economic strength through engineering innovation, the NSF Engineering program aims to foster excellence in...